UCEA Capital Partners
Fox Court, 14 Gray's Inn Road, London, Greater London, WC1X 8HN, United Kingdom
Overview
Single family office providing diverse investment opportunities.
Deals · 12mo
0
Links
Stage focus
Geographic focus
Sector focus
Investment portfolio
- Wavegate Corporation
Led · Series A · Dec 2024
Wavegate Corporation, based in Lake Charles, Louisiana, develops neuromodulation technology for chronic pain centered on its Ellipse™ spinal cord stimulator. Ellipse uses optical reflectometry and the company’s StimuLux™ technology to provide closed-loop adaptive modulation that adjusts stimulation in real time based on spinal cord movement. The platform supports both paresthesia-based and paresthesia-free neuromodulation to help maintain consistent pain relief across a range of patient activities. Ellipse has received FDA Breakthrough Device designation and Wavegate reported successful first-in-human data validating its clinical promise. The company plans to use the Series A proceeds to accelerate R&D, expand clinical trials, and prepare for regulatory approvals en route to commercialization. Wavegate announced a $26 million Series A financing on Dec. 10, 2024.